RNS Number : 4381C
Warpaint London PLC
08 October 2025
 

 

8 October 2025

Warpaint London plc

(the "Company" or the "Group")

Appointment of Joint Corporate Broker

 

Warpaint London plc (AIM: W7L; OTCQX: WPNTF), the specialist supplier of colour cosmetics and owner of the W7, Technic, Skin & Tan, Super Facialist, Dirty Works and Fish Soho brands, is pleased to announce the appointment of Joh. Berenberg, Gossler & Co KG, London ("Berenberg") as joint corporate broker to work alongside Shore Capital, the Group's existing Nominated Adviser and Corporate Broker, with immediate effect.

 

Enquiries:

Warpaint London plc

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer 

c/o IFC

 

Shore Capital (Nominated Adviser & Joint Broker)

Patrick Castle, Daniel Bush, Lucy Bowden - Corporate Advisory

Fiona Conroy - Corporate Broking 

 

Berenberg (Joint Broker)

Clayton Bush, Alex Wright, Alix Mecklenburg-Solodkoff

 

020 7408 4090

 

 

 

0203 207 7800

 

 

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Staton

 

020 3934 6630

 

Warpaint London plc

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to major retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies cosmetics under its other brand names of Man'stuff, Body Collection and Chit Chat, each targeting a different demographic. Additionally, in February 2025, Warpaint acquired a number of leading health, beauty and personal care brands that complement its existing cosmetics brands, including Skin & Tan, Super Facialist, Dirty Works and Fish Soho.


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPBUBDGXSGDGUR